Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$56.36 USD
-2.46 (-4.18%)
Updated Aug 14, 2024 03:59 PM ET
After-Market: $56.56 +0.20 (0.35%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Exact Sciences Corporation [EXAS]
Reports for Purchase
Showing records 301 - 320 ( 369 total )
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
1Q12 Results Review: Timelines on Track: Burn Goes Up Modestly
Provider: AURIGA USA
Analyst: MCDONALD P
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
UPDATE ON COLOGUARD CLINICAL TRIAL & MARKETING STRATEGY-BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
1Q12 Financial Preview - Pivotal Study Likely on Track - Color on Product Extensions & Commercial Strategy Could Be Positive - Reaffirming OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
COMPETITIVE VALIDATION STUDY DATA DOESN''T MEASURE UP - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Reaffirming OUTPERFORM - Competitive Cloud Lifted Following Weak Epigenomics Data
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
3Q11 Results Review: Timelines on Track; Additional Validation Date Imminent
Provider: AURIGA USA
Analyst: MCDONALD P
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
3Q11 Recap -Reaffirming OUTPERFORM - Clinical Trial Enrollment on Track, Instrument Development Above Plan & Validation Data Expected Soon
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z